- Home
- COCP vs CLRB Comparison
COCP vs CLRB Comparison
Compare COCP & CLRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COCP
- CLRB
- Stock Information
- Founded
- COCP 2006
- CLRB 2002
- Country
- COCP United States
- CLRB United States
- Employees
- COCP N/A
- CLRB N/A
- Industry
- COCP Biotechnology: Pharmaceutical Preparations
- CLRB Biotechnology: Pharmaceutical Preparations
- Sector
- COCP Health Care
- CLRB Health Care
- Exchange
- COCP Nasdaq
- CLRB Nasdaq
- Market Cap
- COCP 15.7M
- CLRB 17.6M
- IPO Year
- COCP N/A
- CLRB N/A
- Fundamental
- Price
- COCP $1.80
- CLRB $4.88
- Analyst Decision
- COCP Strong Buy
- CLRB Hold
- Analyst Count
- COCP 1
- CLRB 2
- Target Price
- COCP $6.00
- CLRB N/A
- AVG Volume (30 Days)
- COCP 21.6K
- CLRB 198.9K
- Earning Date
- COCP 08-13-2025
- CLRB 08-12-2025
- Dividend Yield
- COCP N/A
- CLRB N/A
- EPS Growth
- COCP N/A
- CLRB N/A
- EPS
- COCP N/A
- CLRB N/A
- Revenue
- COCP N/A
- CLRB N/A
- Revenue This Year
- COCP N/A
- CLRB N/A
- Revenue Next Year
- COCP N/A
- CLRB N/A
- P/E Ratio
- COCP N/A
- CLRB N/A
- Revenue Growth
- COCP N/A
- CLRB N/A
- 52 Week Low
- COCP $1.12
- CLRB $4.36
- 52 Week High
- COCP $3.26
- CLRB $94.50
- Technical
- Relative Strength Index (RSI)
- COCP 69.71
- CLRB 34.07
- Support Level
- COCP $1.46
- CLRB $4.62
- Resistance Level
- COCP $1.60
- CLRB $5.05
- Average True Range (ATR)
- COCP 0.08
- CLRB 0.88
- MACD
- COCP 0.02
- CLRB -0.35
- Stochastic Oscillator
- COCP 92.31
- CLRB 8.92
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.